United States · 
Who invested in Iterative Scopes?
Iterative Scopes's investors include Obvious Ventures, Eli Lilly, Breyer Capital, Johnson & Johnson Innovation and Time BioVentures, and 1 more on record. Obvious Ventures led its latest round.
United States · Series A startup
Who invested in Iterative Scopes
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $30MAug 2021
- Led by
- Obvious Ventures
- Investors
- 6 (1 led)
The rounds
- Aug 2021Series A$30M
Obvious VenturesLead
Eli Lilly
Breyer Capital- Johnson & Johnson Innovation
Time BioVentures
Seae Ventures
Reported by Firms' own news pagesSEC filing: $32M sold, first sale Jul 2021
Everyone who backed them
Johnson & Johnson InnovationGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Iterative Scopes as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Iterative Scopes
How much has Iterative Scopes raised?
Iterative Scopes has raised $30M across 1 round since 2021.
When did Iterative Scopes last raise?
Iterative Scopes's most recent round was a Series A of $30M in Aug 2021, led by Obvious Ventures.
What was Iterative Scopes's biggest round?
Its most recent round, $30M in Aug 2021, is also its largest on record.
Who backed Iterative Scopes first?
Iterative Scopes's first round on record, in Aug 2021, was backed by Obvious Ventures, Eli Lilly and Breyer Capital and 3 others.
What stage is Iterative Scopes at?
Iterative Scopes's latest named round is a Series A, in Aug 2021.
Where is Iterative Scopes based?
Iterative Scopes is based in the United States.
Who led Iterative Scopes's rounds?
Obvious Ventures led the Series A in 2021.
Companies like Iterative Scopes
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.